SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-20-176628
Filing Date
2020-06-23
Accepted
2020-06-23 17:05:00
Documents
6
Period of Report
2020-07-30

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT d932969dpre14a.htm PRE 14A 486849
2 GRAPHIC g932969g08h41.jpg GRAPHIC 23601
3 GRAPHIC g932969g25h31.jpg GRAPHIC 34435
4 GRAPHIC g932969g48i45.jpg GRAPHIC 57288
5 GRAPHIC g932969img002.jpg GRAPHIC 117790
6 GRAPHIC g932969img003.jpg GRAPHIC 126930
  Complete submission text file 0001193125-20-176628.txt   984307
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39045 | Film No.: 20983041
SIC: 2834 Pharmaceutical Preparations